Kronox Lab Sciences Limited has achieved a significant milestone in its expansion plans by securing environmental clearance from the Central Government for the construction of its Unit-IV at Dahej. This development marks the completion of all necessary statutory approvals required for the project, paving the way for the company to proceed with its construction plans.

Key Highlights

• Environmental clearance received from the Central Government
• All statutory approvals for Unit-IV construction now complete
• Project location: Dahej

Background

The environmental clearance was the final pending approval, as mentioned by the company during its Annual General Meeting held on August 18, 2025. Prior to this, Kronox Lab Sciences had already obtained various approvals from different authorities, demonstrating its commitment to regulatory compliance and sustainable development.

Company Statement

In an official communication to the stock exchanges, Nikhil Goswami, Company Secretary of Kronox Lab Sciences Limited, stated, "The Company is happy to announce that Company has received approval of ENVIRONMENTAL CLEARANCE from Central Government." This statement underscores the significance of this approval in the company's growth strategy.

Implications

The receipt of environmental clearance is a crucial step for Kronox Lab Sciences, as it allows the company to move forward with its expansion plans. The construction of Unit-IV in Dahej is likely to enhance the company's production capabilities and potentially contribute to its future growth prospects.

Investor Information

Shareholders and potential investors should note that this development represents a positive step in the company's expansion strategy. However, as with any major project, the actual impact on the company's performance will depend on various factors, including successful implementation and market conditions.

Kronox Lab Sciences Limited continues to demonstrate its commitment to growth while adhering to regulatory requirements and environmental standards. The company's proactive approach in securing all necessary approvals showcases its dedication to transparent and compliant business practices.

Kronox Lab Sciences Limited, a prominent player in the laboratory sciences sector, has released its financial results for the first quarter of the fiscal year 2025-26, showcasing a mixed performance with signs of sequential recovery despite year-on-year pressures.

Financial Highlights

Quarter-on-Quarter Performance

Kronox Lab Sciences demonstrated resilience in its quarter-on-quarter (QoQ) performance:

• Total income increased by 2.30% from the previous quarter
• Net profit after tax surged by an impressive 94.70% sequentially
• EPS nearly doubled compared to the last quarter

Year-on-Year Comparison

Despite the sequential improvements, the company faced challenges when compared to the same quarter last year:

• Total income declined by 5.20% year-on-year (YoY)
• Net profit after tax decreased by 65.10% YoY
• EPS also saw a 65.10% reduction compared to Q1 of the previous fiscal year

Financial Position

The company's paid-up equity share capital remained stable at ₹15.62 crore, indicating no changes in its equity structure during the quarter.

Market Disclosure

In compliance with regulatory requirements, Kronox Lab Sciences Limited has published its unaudited financial results for the quarter ended June 30, 2025, in leading newspapers. The company's commitment to transparency is evident from its prompt disclosure to the National Stock Exchange of India Limited and BSE Limited.

Conclusion

Kronox Lab Sciences' Q1 FY26 results paint a picture of a company in transition, successfully achieving sequential growth while grappling with year-on-year headwinds. As the fiscal year progresses, stakeholders will be keenly watching how the company builds on its quarter-on-quarter improvements and addresses the challenges reflected in its year-on-year comparisons.